These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3177227)

  • 1. A symposium: Calcium, the cardiovascular system and the kidney. April 7-9, 1988, Maui, Hawaii. Proceedings.
    Am J Cardiol; 1988 Oct; 62(11):1G-120G. PubMed ID: 3177227
    [No Abstract]   [Full Text] [Related]  

  • 2. A symposium: Role of calcium entry-blocking drugs in hypertension. March 1985, Maui, Hawaii.
    Am J Cardiol; 1985 Dec; 56(16):1H-111H. PubMed ID: 4072938
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of calcium-channel blockers in pregnancy.
    Lewis R; Sibai BM
    New Horiz; 1996 Feb; 4(1):115-22. PubMed ID: 8689266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [T-type calcium channel].
    Ono K
    Nihon Yakurigaku Zasshi; 2006 Sep; 128(3):185-7. PubMed ID: 17139820
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cardiovascular effects of calcium antagonists].
    Pasanisi F; Marino A
    Clin Ter; 1989 Jul; 130(1):3-10. PubMed ID: 2529078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium antagonism with felodipine in essential hypertension. Effects on cardiovascular and renal function, the sympathetic and the renin-angiotensin-aldosterone systems, glucose tolerance and glucoregulatory hormones.
    Katzman PL
    Acta Med Scand Suppl; 1987; 720():1-62. PubMed ID: 3328471
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of calcium channel blockers in the management of hypertension; and Calcium channel blockers: their evolving role in the management of hypertension. Proceedings of two symposiums. November 10, 1985, Washington, D.C.; and March 6-8, 1986, Key Biscayne, Florida.
    Am J Med; 1986 Dec; 81(6A):1-42. PubMed ID: 3799660
    [No Abstract]   [Full Text] [Related]  

  • 8. Calcium antagonists as first-choice therapy for low-renin essential hypertension.
    Bühler FR
    Kidney Int; 1989 Aug; 36(2):295-305. PubMed ID: 2674520
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiac consequences of aldosterone excess in human hypertension.
    Rossi GP
    Am J Hypertens; 2006 Jan; 19(1):10-2. PubMed ID: 16461183
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic uses of calcium channel blockers.
    Zaret GM
    Am Fam Physician; 1983 Apr; 27(4):210-21. PubMed ID: 6837404
    [No Abstract]   [Full Text] [Related]  

  • 11. Can calcium channel blockers preserve renal function better than diuretics during antihypertensive treatment?
    Fukuda M; Kimura G
    Arch Intern Med; 2005 Jun; 165(11):1312; author reply 1312-3. PubMed ID: 15956015
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular advantages of a third generation calcium antagonist. Symposium on lacidipine. Foreword.
    Zanchetti A
    Drugs; 1999; 57 Suppl 1():2 p preceding 1. PubMed ID: 10529077
    [No Abstract]   [Full Text] [Related]  

  • 13. [Role of calcium inhibitors in the treatment of arterial hypertension. Satellite symposium of the seminar on arterial hypertension].
    Arch Mal Coeur Vaiss; 1985 Nov; 78 Spec No():1-90. PubMed ID: 3937499
    [No Abstract]   [Full Text] [Related]  

  • 14. Calcium channel blockers and nephroprotection.
    Ungar A; Di Serio C; Lambertucci L; Monami M; Masotti G
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):31-9. PubMed ID: 16640171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium antagonists in hypertension. 25th anniversary international symposium. Basel, Switzerland, February 11-12, 1988.
    J Cardiovasc Pharmacol; 1988; 12 Suppl 6():S1-224. PubMed ID: 2468887
    [No Abstract]   [Full Text] [Related]  

  • 16. Calcium antagonists ameliorate hypertensive hemodynamic abnormalities. Official satellite symposium of the American Society of Hypertension.
    Am J Hypertens; 1989 Jun; 2(6 Pt 2):153S-206S. PubMed ID: 2751848
    [No Abstract]   [Full Text] [Related]  

  • 17. A symposium: Future directions in calcium channel blockade with focus on systemic hypertension. November 10, 1985, Washington, DC.
    Am J Cardiol; 1986 Sep; 58(8):1D-40D. PubMed ID: 3766405
    [No Abstract]   [Full Text] [Related]  

  • 18. Calcium antagonists for antihypertensive baseline therapy. First International Nitrendipine Symposium. Interlaken, April 13-14, 1984.
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S929-1113. PubMed ID: 6085378
    [No Abstract]   [Full Text] [Related]  

  • 19. Understanding the calcium channel blockers.
    Stone KS; Scordo KA
    Heart Lung; 1984 Sep; 13(5):563-73. PubMed ID: 6088433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A symposium: Calcium antagonists in hypertension--focus on verapamil. November 15-17, 1985, Mexico City, Mexico. November 27, 1984, Bangkok, Thailand.
    Am J Cardiol; 1986 Feb; 57(7):1D-107D. PubMed ID: 3953426
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.